BTIG Maintains Buy on Precision BioSciences, Lowers Price Target to $2
Portfolio Pulse from richadhand@benzinga.com
BTIG analyst Thomas Shrader maintains a Buy rating on Precision BioSciences (NASDAQ:DTIL) but lowers the price target from $6 to $2.
July 28, 2023 | 5:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BTIG analyst maintains a Buy rating on Precision BioSciences but lowers the price target from $6 to $2.
The lowered price target from $6 to $2 by BTIG analyst Thomas Shrader indicates a potential downside for Precision BioSciences' stock in the short term. However, the maintained Buy rating suggests that the analyst still sees long-term potential in the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100